MR BIOINVEST ApS: Financial statements 2019
CVR: 25942817
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
MR BIOINVEST ApS (CVR 25942817) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK -32,500 and a net result of DKK 2,864,640 compared with DKK -1,371,442 the year before. Equity in the 2019 report amounted to DKK 23,093,505. The solvency ratio was 99.2%.
- Gross Profit
- DKK -32,500
- Profit/Loss
- DKK 2,864,640
- Equity
- DKK 23,093,505
- Total Assets
- DKK 23,290,213
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | -33K | 2.9M | 23.1M | 0 |
| 2018 | - | -63K | -1.4M | 20.2M | 0 |
| 2017 | - | -48K | 437K | 21.6M | 0 |
| 2016 | - | -5K | 18.8M | 21.2M | - |
| 2015 | 0 | 0 | 0 | 2.3M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
MR BIOINVEST ApS has published its annual report for 2018. Gross profit came to DKK -63,252, and the net result was DKK -1,371,442.
About MR BIOINVEST ApS
MR BIOINVEST ApS is a Danish company of the type Anpartsselskab based in Gentofte, founded in 2001. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of Mads Aage Laustsen. The company is owned by Mads Aage Laustsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -31,875 and a net result of DKK 1,503,262 compared with DKK 1,669,196 the year before. Equity in the 2025 report amounted to DKK 28,217,549.